Cite
HARVARD Citation
Eaton, K. et al. (n.d.). DOP69 Ozanimod for induction treatment of Moderate-to-Severe Ulcerative Colitis: Results from a systematic literature review and network meta-analyses. Journal of Crohn's and colitis. pp. S103-S105. [Online].